BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 21219537)

  • 21. Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.
    Zhang N; Zhang J; Shuai L; Zha L; He M; Huang Z; Wang Z
    Int J Oncol; 2012 Jun; 40(6):2038-48. PubMed ID: 22407433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression.
    Chang KP; Kao HK; Liang Y; Cheng MH; Chang YL; Liu SC; Lin YC; Ko TY; Lee YS; Tsai CL; Wang TH; Hao SP; Tsai CN
    Ann Surg Oncol; 2010 Jul; 17(7):1945-56. PubMed ID: 20309641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
    Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
    Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
    Hung PS; Kao SY; Shih YH; Chiou SH; Liu CJ; Chang KW; Lin SC
    J Pathol; 2008 Feb; 214(3):368-76. PubMed ID: 18085517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer.
    Lu W; Zuo Y; Feng Y; Zhang M
    Tumour Biol; 2014 Nov; 35(11):10699-705. PubMed ID: 25070488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin inhibits carcinogen and nicotine-induced Mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma.
    Clark CA; McEachern MD; Shah SH; Rong Y; Rong X; Smelley CL; Caldito GC; Abreo FW; Nathan CO
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1586-95. PubMed ID: 20851953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
    Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
    Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers.
    Li F; Shanmugam MK; Siveen KS; Wang F; Ong TH; Loo SY; Swamy MM; Mandal S; Kumar AP; Goh BC; Kundu T; Ahn KS; Wang LZ; Hui KM; Sethi G
    Oncotarget; 2015 Mar; 6(7):5147-63. PubMed ID: 25762616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
    Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z
    Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance.
    Jia Y; Zhang W; Liu H; Peng L; Yang Z; Lou J
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):377-85. PubMed ID: 21833590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial.
    Cullen KJ; Schumaker L; Nikitakis N; Goloubeva O; Tan M; Sarlis NJ; Haddad RI; Posner MR
    J Clin Oncol; 2009 Dec; 27(36):6222-8. PubMed ID: 19917838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer.
    Kudo Y; Ogawa I; Kitajima S; Kitagawa M; Kawai H; Gaffney PM; Miyauchi M; Takata T
    Cancer Res; 2006 Jul; 66(14):6928-35. PubMed ID: 16849536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.
    Rahadiani N; Ikeda J; Mamat S; Matsuzaki S; Ueda Y; Umehara R; Tian T; Wang Y; Enomoto T; Kimura T; Aozasa K; Morii E
    Cancer Sci; 2011 Apr; 102(4):903-8. PubMed ID: 21231983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
    Schröck A; Bode M; Göke FJ; Bareiss PM; Schairer R; Wang H; Weichert W; Franzen A; Kirsten R; van Bremen T; Queisser A; Kristiansen G; Heasley L; Bootz F; Lengerke C; Perner S
    Carcinogenesis; 2014 Jul; 35(7):1636-42. PubMed ID: 24743512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor.
    Mandic R; Rodgarkia-Dara CJ; Krohn V; Wiegand S; Grénman R; Werner JA
    Anticancer Res; 2009 Apr; 29(4):1181-7. PubMed ID: 19414362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity.
    Hsu DS; Chang SY; Liu CJ; Tzeng CH; Wu KJ; Kao JY; Yang MH
    Cancer Sci; 2010 Apr; 101(4):1029-37. PubMed ID: 20175780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
    Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
    Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.
    Rigalli JP; Reuter T; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J; Theile D
    Cancer Chemother Pharmacol; 2013 May; 71(5):1335-43. PubMed ID: 23479137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
    Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ
    Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.